Learner Objectives:
1. Outline the benefits of neoadjuvant and perioperative chemoimmunotherapy for NSCLC.
2. Examine the risks of surgery for lung cancer.
3. Review the benefits and limitations of surgery for patients with mediastinal nodal spread.
4. Review recent advances in the diagnosis, staging, and risk stratification of patients with prostate and bladder cancer, including the role of molecular biomarkers and advanced imaging.
5. Discuss current evidence supporting the use of systemic therapies, including novel hormonal agents, immunotherapy, antibody-drug conjugates, targeted therapies, and combination treatment strategies across disease stages.
6. Evaluate evolving multidisciplinary approaches to the management of localized, locally advanced, and metastatic prostate and bladder cancers, with emphasis on patient selection and individualized treatment planning.
7. Apply current clinical trial data and guideline recommendations to optimize treatment sequencing, toxicity management, and shared decision-making to improve patient outcomes and quality of life.
8. Examine the evidence on how exogenous hormones (oral contraceptives and menopausal hormone therapy) influence breast cancer risk in average and high-risk women.
9. Recognize that the type of hormone used impacts risk.
10. Assess menopausal hormone therapy in the very high-risk woman (BRCA carriers).
11. Review data for the use of hormones in breast cancer survivors (vaginal and systemic).
12. Describe the evidence supporting physical activity for symptoms, function, and selected survival outcomes after cancer diagnosis.
13. Identify when patients may begin self-directed activity versus when they need rehabilitation, physical therapy, or trained exercise support.
14. Apply a practical workflow to assess, recommend, and refer patients for physical activity support.
15. Describe advances in early detection of pancreatic cancer.
16. Review the advances in treatment of pancreatic cancer.
17. Outline the advances in prevention of pancreatic cancer.
18. Define burnout and factors affecting burnout in healthcare.
19. Describe the rates of burnout in oncology and risk and protective factors.
20. Demonstrate at least three coping strategies for burnout, including self-care and structural/institutional recommendations.
